We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 28, 2021

Paclitaxel Plus Bevacizumab Is Safe and Effective in Breast Cancer Patients With Visceral Crisis

The Breast


Additional Info

The Breast
The Efficacy and Safety of Paclitaxel Plus Bevacizumab Therapy in Breast Cancer Patients With Visceral Crisis
Breast 2021 Apr 10;[EPub Ahead of Print], C Funasaka, Yi Naito, S Kusuhara, et al

Further Reading